China Universal Asset Management Co. Ltd. Boosts Holdings in SPDR S&P Biotech ETF $XBI

China Universal Asset Management Co. Ltd. grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 868.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,919 shares of the exchange traded fund’s stock after acquiring an additional 4,411 shares during the quarter. China Universal Asset Management Co. Ltd.’s holdings in SPDR S&P Biotech ETF were worth $493,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of XBI. AdvisorNet Financial Inc increased its holdings in shares of SPDR S&P Biotech ETF by 7.3% during the 3rd quarter. AdvisorNet Financial Inc now owns 1,463 shares of the exchange traded fund’s stock worth $147,000 after buying an additional 100 shares during the last quarter. Sequoia Financial Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 3.1% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 3,393 shares of the exchange traded fund’s stock valued at $340,000 after purchasing an additional 101 shares in the last quarter. CWC Advisors LLC. lifted its stake in shares of SPDR S&P Biotech ETF by 2.8% in the third quarter. CWC Advisors LLC. now owns 5,707 shares of the exchange traded fund’s stock worth $572,000 after acquiring an additional 157 shares in the last quarter. Mission Hills Financial Advisory LLC boosted its stake in shares of SPDR S&P Biotech ETF by 0.4% during the 3rd quarter. Mission Hills Financial Advisory LLC now owns 35,841 shares of the exchange traded fund’s stock valued at $3,591,000 after buying an additional 157 shares during the last quarter. Finally, Patten & Patten Inc. TN boosted its stake in SPDR S&P Biotech ETF by 2.9% during the 3rd quarter. Patten & Patten Inc. TN now owns 5,826 shares of the exchange traded fund’s stock valued at $584,000 after acquiring an additional 165 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 1.5%

Shares of NYSEARCA XBI opened at $124.78 on Friday. The company has a market capitalization of $8.34 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $132.09. The business has a 50 day simple moving average of $124.65 and a 200-day simple moving average of $111.25.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.